Loading clinical trials...
Loading clinical trials...
The biological diagnosis of AD is actually performed by analysing Aβ1-40 and Aβ1-42 peptides, total tau and tau phosphorylated at Thr181 (p-Tau181) from cerebrospinal fluid (CSF) samples obtained by l...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
NCT07550023 · Short Chain Fatty Acids Concentration in Stools, Gut Microbiota Diversity and Composition, and more
NCT07033494 · Early Alzheimer's Disease
NCT07486401 · Asthma Exacerbations, Biomarkers / Blood, and more
NCT06159673 · Alzheimer's Disease Psychosis
NCT07457138 · Subjective Cognitive Decline (SCD), Functional Cognitive Disorder, and more
CHRU Amiens
Amiens
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions